Abstract

Objectives: The purpose of this study is to evaluate the safety and performance of the Long Pulse (LP) 1064 nm Nd:YAG laser for the treatment of leg vascular lesions. Introduction: Telangiectasias are dilated or broken blood vessels located near the surface of the skin or mucous membranes. They often appear as fine pink or red lines, which temporarily whiten when pressed. They are extremely common. While sclerotherapy is considered the gold standard for treating these lesions, lasers offer some advantages. Materials / method: Forty-two women were treated for leg vascular lesions with a long-pulse (LP) 1064-nm Nd:YAG laser. Efficacy was assessed by the physician using the Global Aesthetic Improvement Scale (GAIS) with 10% increments between 0% and 100%. Patient satisfaction and pain were assessed using the 0-10 Numeric Satisfaction Rating Scale and the Numeric Pain Rating Scale, respectively. Adverse events were monitored. Results: Three months after the last treatment, the mean GAIS score was 81.4% ± 0.8% and 88% of patients rated their satisfaction as 8 or higher. The mean pain score was 3.97 ± 1 and only a mild side effect of occasional crusting was observed after each treatment. No adverse events were reported. Conclusion: This study demonstrates the safety and efficacy of the 1064 Nd:YAG laser for the management of leg vascular lesions and further supports its potential as the treatment of choice.